Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (356)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
43
2023
2454
2.810
Why?
HIV-1
23
2023
771
2.800
Why?
Respiratory Syncytial Virus Vaccines
6
2022
24
2.620
Why?
Respiratory Syncytial Virus Infections
6
2022
99
2.420
Why?
Respiratory Syncytial Virus, Human
6
2022
61
2.370
Why?
Anti-Retroviral Agents
12
2023
206
1.920
Why?
Infectious Disease Transmission, Vertical
15
2023
156
1.850
Why?
Viral Proteins
3
2020
287
1.780
Why?
HIV Antibodies
10
2023
49
1.760
Why?
Antibodies, Viral
7
2022
537
1.140
Why?
Antibodies, Neutralizing
7
2022
223
1.030
Why?
Antibodies, Monoclonal
5
2021
1274
0.830
Why?
Pregnancy Complications, Infectious
7
2016
296
0.820
Why?
Gene Deletion
2
2020
356
0.800
Why?
AIDS Vaccines
7
2018
41
0.750
Why?
Atazanavir Sulfate
2
2017
41
0.700
Why?
Breast Feeding
3
2023
383
0.690
Why?
HIV Protease Inhibitors
2
2017
64
0.680
Why?
Ritonavir
2
2017
72
0.680
Why?
Anti-HIV Agents
9
2023
666
0.660
Why?
Vaccines, Attenuated
6
2022
113
0.640
Why?
Infant, Newborn
20
2023
5209
0.580
Why?
Nelfinavir
1
2016
8
0.560
Why?
Lyme Disease
1
2016
32
0.550
Why?
Syncope
1
2016
36
0.550
Why?
Lopinavir
1
2016
29
0.550
Why?
Patient Dropouts
1
2016
66
0.540
Why?
Vaccination
5
2020
1221
0.540
Why?
Bradycardia
1
2016
48
0.540
Why?
Infant
28
2023
8154
0.520
Why?
Health Resources
1
2016
129
0.500
Why?
Infant, Newborn, Diseases
1
2016
107
0.490
Why?
HIV
5
2014
207
0.460
Why?
Patient Compliance
2
2018
529
0.450
Why?
HIV Envelope Protein gp120
5
2017
56
0.440
Why?
Immunogenicity, Vaccine
4
2021
26
0.420
Why?
Child
35
2023
18921
0.410
Why?
Virus Replication
4
2020
395
0.400
Why?
CD4-Positive T-Lymphocytes
2
2017
977
0.400
Why?
T-Lymphocytes, Cytotoxic
4
2005
159
0.390
Why?
Humans
65
2023
117608
0.360
Why?
Female
42
2023
60910
0.350
Why?
Viral Load
9
2017
406
0.310
Why?
Male
34
2021
56901
0.310
Why?
Adolescent
25
2023
18254
0.300
Why?
HIV Seropositivity
2
2023
111
0.300
Why?
Double-Blind Method
3
2020
1681
0.300
Why?
RNA, Viral
8
2023
565
0.290
Why?
Antibodies, Bacterial
2
2018
124
0.270
Why?
Dyslipidemias
2
2017
160
0.260
Why?
Antiretroviral Therapy, Highly Active
6
2017
257
0.260
Why?
Immunoenzyme Techniques
1
2005
194
0.250
Why?
Immunoglobulin G
3
2022
788
0.250
Why?
Viremia
3
2011
126
0.240
Why?
Young Adult
12
2021
10719
0.240
Why?
Gene Products, gag
2
1994
36
0.230
Why?
Child, Preschool
20
2022
9340
0.230
Why?
Drug Resistance, Viral
2
2016
98
0.210
Why?
Pregnancy
10
2023
5709
0.210
Why?
CD4 Lymphocyte Count
4
2017
259
0.210
Why?
Growth Differentiation Factor 15
1
2021
35
0.200
Why?
Half-Life
1
2021
147
0.200
Why?
T-Lymphocytes
2
2009
1770
0.200
Why?
Mitochondrial Diseases
1
2021
79
0.190
Why?
Immunization Schedule
2
2018
188
0.190
Why?
Drug Therapy, Combination
4
2017
965
0.190
Why?
Lymphocyte Activation
4
2017
1064
0.190
Why?
RNA, Small Untranslated
1
2020
16
0.190
Why?
Fibroblast Growth Factors
1
2021
173
0.180
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.180
Why?
Cytokines
2
2021
1857
0.180
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
180
0.170
Why?
Squalene
2
2017
5
0.170
Why?
Body Temperature
1
2020
212
0.170
Why?
Point Mutation
1
2020
225
0.170
Why?
Immunologic Memory
2
2021
313
0.170
Why?
Insulin Resistance
3
2019
1155
0.170
Why?
Haemophilus Vaccines
2
2018
28
0.160
Why?
Immunocompromised Host
2
2000
197
0.160
Why?
Interleukin-12
1
1998
110
0.150
Why?
Darunavir
1
2017
17
0.150
Why?
Metabolic Syndrome
1
2021
381
0.150
Why?
Mycobacterium Infections, Nontuberculous
2
2012
335
0.150
Why?
Therapeutic Equipoise
1
2017
2
0.150
Why?
Dose-Response Relationship, Drug
1
2021
1893
0.150
Why?
Immunoglobulin A
2
2017
173
0.150
Why?
Interferon-gamma
5
2012
732
0.150
Why?
Antibody Formation
1
2018
275
0.150
Why?
Lymphopoiesis
1
2017
24
0.150
Why?
Uganda
1
2017
74
0.150
Why?
High-Throughput Screening Assays
1
2018
124
0.150
Why?
Receptors, CCR5
1
2017
54
0.140
Why?
CD4-CD8 Ratio
1
2016
19
0.140
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
16
0.140
Why?
Adult
15
2023
31151
0.140
Why?
Mothers
3
2017
683
0.140
Why?
Adoption
1
2016
38
0.140
Why?
Virus Latency
1
2016
80
0.130
Why?
Continuity of Patient Care
1
2018
255
0.130
Why?
Early Diagnosis
1
2016
222
0.130
Why?
Chickenpox Vaccine
1
2015
69
0.130
Why?
Body Height
2
2017
187
0.130
Why?
Gene Products, env
1
1994
7
0.130
Why?
Disease Susceptibility
1
2017
327
0.130
Why?
Haemophilus influenzae type b
1
2014
11
0.130
Why?
Bacterial Capsules
1
2014
32
0.120
Why?
Antibody Affinity
1
2014
54
0.120
Why?
Developing Countries
1
2016
249
0.120
Why?
Chickenpox
1
2015
95
0.120
Why?
Acquired Immunodeficiency Syndrome
2
2000
216
0.120
Why?
Parotitis
1
2014
7
0.120
Why?
Retrospective Studies
8
2023
12904
0.120
Why?
Lipids
1
2017
587
0.120
Why?
Puberty, Delayed
1
2013
5
0.120
Why?
Intestines
1
2017
328
0.120
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.110
Why?
Vaccines
1
2018
380
0.110
Why?
Mycobacterium chelonae
1
1993
8
0.110
Why?
Patient Selection
1
2017
659
0.110
Why?
Mitochondria
2
2021
775
0.110
Why?
Cohort Studies
7
2021
5057
0.110
Why?
Bone Density
1
2016
447
0.110
Why?
Lamivudine
3
2023
59
0.110
Why?
Cell Movement
1
2017
880
0.110
Why?
Child Development
1
2017
407
0.110
Why?
Cardiovascular Diseases
2
2016
1794
0.110
Why?
Pediatric Obesity
1
2019
512
0.110
Why?
Prospective Studies
4
2017
6426
0.100
Why?
Clinical Trials as Topic
1
2017
958
0.100
Why?
STAT1 Transcription Factor
1
2012
65
0.100
Why?
Body Weight
2
2017
901
0.100
Why?
Body Fat Distribution
1
2011
45
0.100
Why?
United States
9
2023
12426
0.100
Why?
Epitopes
2
2022
438
0.100
Why?
Mycobacterium avium Complex
1
2012
92
0.100
Why?
Biomedical Research
1
2017
600
0.090
Why?
Research Design
1
2017
964
0.090
Why?
Exercise
1
2021
1631
0.090
Why?
Prenatal Exposure Delayed Effects
1
2016
472
0.090
Why?
Respiratory Tract Infections
1
2014
329
0.090
Why?
Interleukin-2
2
2003
418
0.090
Why?
Freezing
1
2009
86
0.080
Why?
Biomarkers
4
2021
3562
0.080
Why?
Staff Development
1
2009
39
0.080
Why?
Algorithms
1
2016
1519
0.080
Why?
Blood
1
2009
96
0.080
Why?
Phenotype
1
2017
2894
0.080
Why?
Age Factors
4
2019
2961
0.080
Why?
Specimen Handling
1
2009
161
0.080
Why?
Lymphocyte Subsets
2
2009
76
0.080
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
804
0.080
Why?
Withholding Treatment
1
2008
67
0.080
Why?
Adipose Tissue
1
2011
582
0.080
Why?
Faculty
1
2009
135
0.080
Why?
Enterovirus A, Human
1
2007
12
0.080
Why?
Leukocytes, Mononuclear
3
2013
507
0.070
Why?
Vaccines, Synthetic
3
2005
125
0.070
Why?
Central Nervous System Viral Diseases
1
2007
63
0.070
Why?
Polymerase Chain Reaction
4
2011
1005
0.070
Why?
Academic Medical Centers
1
2009
424
0.070
Why?
DNA, Viral
2
2000
349
0.070
Why?
Cytotoxicity, Immunologic
2
1998
194
0.070
Why?
C-Reactive Protein
2
2021
370
0.060
Why?
Enterovirus Infections
1
2007
164
0.060
Why?
Isoantigens
1
1984
17
0.060
Why?
Colorado
3
2023
4144
0.060
Why?
Cell Line
3
2012
2674
0.060
Why?
Disease Outbreaks
1
2007
324
0.060
Why?
Follow-Up Studies
3
2021
4528
0.060
Why?
Immunity, Cellular
1
2006
267
0.060
Why?
Linear Models
2
2020
810
0.060
Why?
Comorbidity
2
2021
1503
0.060
Why?
Risk Factors
4
2021
8917
0.060
Why?
Thymus Gland
1
1984
298
0.060
Why?
Cote d'Ivoire
1
2023
8
0.060
Why?
Tablets
1
2023
36
0.060
Why?
Immunophenotyping
2
1994
275
0.060
Why?
Respiratory Syncytial Viruses
1
2022
48
0.050
Why?
Regression Analysis
2
2021
979
0.050
Why?
Zidovudine
2
2015
77
0.050
Why?
Cough
1
2022
102
0.050
Why?
Emtricitabine
1
2023
147
0.050
Why?
Pyridones
1
2023
116
0.050
Why?
Polysorbates
2
2017
35
0.050
Why?
Tenofovir
1
2023
203
0.050
Why?
Lung
1
2014
3595
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
48
0.050
Why?
Public Health Surveillance
1
2021
60
0.050
Why?
Ganciclovir
1
2000
49
0.050
Why?
Cross-Sectional Studies
3
2021
4534
0.050
Why?
Sex Factors
2
2019
1756
0.050
Why?
Computer Simulation
1
2005
908
0.050
Why?
Adjuvants, Immunologic
2
2017
206
0.050
Why?
Africa
1
2020
97
0.050
Why?
Injections, Subcutaneous
1
2020
137
0.050
Why?
Diagnostic Tests, Routine
1
2021
91
0.050
Why?
Symptom Assessment
1
2021
122
0.040
Why?
Cost-Benefit Analysis
1
2023
545
0.040
Why?
HIV Seronegativity
1
2019
24
0.040
Why?
HLA-D Antigens
1
1999
36
0.040
Why?
Prevalence
2
2016
2307
0.040
Why?
Case-Control Studies
2
2019
3121
0.040
Why?
Risk
1
2021
842
0.040
Why?
Longitudinal Studies
2
2017
2487
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
43
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Mutation
3
2018
3428
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
48
0.040
Why?
Hospitals
1
2023
596
0.040
Why?
Vaccines, Combined
1
2018
46
0.040
Why?
Cholesterol, HDL
1
2019
196
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
25
0.040
Why?
Cytomegalovirus Infections
1
2000
186
0.040
Why?
Hepatitis B Vaccines
1
2018
46
0.040
Why?
Odds Ratio
1
2021
988
0.040
Why?
Nutrition Surveys
1
2019
231
0.040
Why?
Drug Resistance, Microbial
2
2000
67
0.040
Why?
Case Management
1
2018
62
0.040
Why?
Cholesterol, LDL
1
2019
317
0.040
Why?
Antigens, Viral
1
1998
177
0.040
Why?
Cholesterol
1
2019
373
0.040
Why?
Immune Tolerance
1
1999
329
0.040
Why?
Reproducibility of Results
1
2005
2837
0.040
Why?
Epitopes, T-Lymphocyte
1
1998
170
0.040
Why?
Treatment Adherence and Compliance
1
2017
20
0.040
Why?
Triglycerides
1
2019
500
0.040
Why?
Disease Management
1
2021
560
0.040
Why?
Lymphocyte Count
2
2009
134
0.040
Why?
Uncertainty
1
2017
100
0.040
Why?
Cell Division
1
1998
767
0.030
Why?
Treatment Failure
1
2017
339
0.030
Why?
Multicenter Studies as Topic
1
2017
250
0.030
Why?
T-Lymphocyte Subsets
1
1998
392
0.030
Why?
Time-to-Treatment
1
2017
147
0.030
Why?
Nevirapine
1
2015
14
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1235
0.030
Why?
Maternal Exposure
1
2017
142
0.030
Why?
Malnutrition
1
2016
67
0.030
Why?
Seroepidemiologic Studies
1
2015
146
0.030
Why?
Treatment Outcome
2
2021
9295
0.030
Why?
Sexual and Gender Minorities
1
2018
139
0.030
Why?
Patient Outcome Assessment
1
2016
121
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Antiviral Agents
1
2000
656
0.030
Why?
Coinfection
1
2016
119
0.030
Why?
Counseling
1
2018
341
0.030
Why?
Neutropenia
1
2015
129
0.030
Why?
Vaccines, Conjugate
1
2014
62
0.030
Why?
Global Health
1
2017
303
0.030
Why?
Anemia
1
2015
145
0.030
Why?
Cells, Cultured
2
2008
3962
0.030
Why?
Electron Transport Complex IV
1
2013
50
0.030
Why?
Maternal-Fetal Exchange
1
2014
156
0.030
Why?
Electron Transport Complex I
1
2013
36
0.030
Why?
Thrombocytopenia
1
2015
183
0.030
Why?
Tuberculosis, Cutaneous
1
1993
4
0.030
Why?
HIV Reverse Transcriptase
1
1993
27
0.030
Why?
Severity of Illness Index
1
2021
2643
0.030
Why?
Flow Cytometry
2
2009
1066
0.030
Why?
Radiography, Thoracic
1
2014
160
0.030
Why?
CD8 Antigens
1
1993
70
0.030
Why?
CD3 Complex
1
1993
93
0.030
Why?
Lymphocytes
1
1994
341
0.030
Why?
Oxidative Phosphorylation
1
2013
157
0.030
Why?
Drug Administration Schedule
2
2008
727
0.030
Why?
Blood Pressure
1
2019
1634
0.030
Why?
Medication Adherence
1
2017
556
0.030
Why?
DNA, Mitochondrial
1
2013
185
0.030
Why?
Blood Transfusion
1
1994
260
0.030
Why?
Hospitalization
1
2021
1772
0.030
Why?
P-Selectin
1
2011
26
0.030
Why?
Antigens, CD
1
1994
451
0.030
Why?
E-Selectin
1
2011
52
0.030
Why?
Heteroduplex Analysis
1
2011
1
0.030
Why?
Tuberculosis, Pulmonary
1
1993
112
0.030
Why?
Chemokine CCL2
1
2011
120
0.020
Why?
Healthcare Disparities
1
2017
488
0.020
Why?
Cell Proliferation
2
2009
2233
0.020
Why?
Fibrinogen
1
2011
150
0.020
Why?
Hyperlipidemias
1
2011
125
0.020
Why?
Protein Multimerization
1
2012
160
0.020
Why?
Absorptiometry, Photon
1
2011
227
0.020
Why?
Cell Adhesion Molecules
1
2011
171
0.020
Why?
Infant, Premature
1
1994
481
0.020
Why?
Interferon-alpha
1
2012
191
0.020
Why?
Cross Infection
1
1993
204
0.020
Why?
Nontuberculous Mycobacteria
1
1993
207
0.020
Why?
Diagnosis, Differential
1
2014
1346
0.020
Why?
Pokeweed Mitogens
1
2009
6
0.020
Why?
L-Selectin
1
2009
25
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
35
0.020
Why?
Leukocyte Common Antigens
1
2009
76
0.020
Why?
Obesity
1
2021
2660
0.020
Why?
Meningitis, Aseptic
1
2007
15
0.020
Why?
Interleukin-6
1
2011
678
0.020
Why?
Virus Cultivation
1
2007
25
0.020
Why?
Multivariate Analysis
1
2011
1463
0.020
Why?
Phosphorylation
1
2012
1591
0.020
Why?
Pregnancy Outcome
1
2010
351
0.020
Why?
Data Interpretation, Statistical
1
2009
332
0.020
Why?
Cerebrospinal Fluid
1
2007
92
0.020
Why?
Paralysis
1
2007
67
0.020
Why?
Multiple Organ Failure
1
2007
115
0.020
Why?
B-Lymphocytes
1
2012
771
0.020
Why?
Respiratory System
1
2007
141
0.020
Why?
Kinetics
1
2010
1586
0.020
Why?
CD8-Positive T-Lymphocytes
1
2011
693
0.020
Why?
Genotype
1
2011
1858
0.020
Why?
Immunoglobulin A, Secretory
1
2005
11
0.020
Why?
Cell Survival
1
2009
1029
0.020
Why?
Phosphates
1
1987
164
0.020
Why?
Encephalitis
1
2007
127
0.020
Why?
Muscles
1
1987
331
0.020
Why?
Gastrointestinal Tract
1
2007
174
0.020
Why?
Mucous Membrane
1
2005
109
0.020
Why?
DNA-Binding Proteins
1
2012
1340
0.020
Why?
Antigen-Antibody Reactions
1
1984
50
0.020
Why?
Chemistry, Physical
1
1984
41
0.020
Why?
Chemical Phenomena
1
1984
82
0.020
Why?
Myasthenia Gravis
1
1984
18
0.020
Why?
Sequence Analysis, DNA
1
2007
741
0.020
Why?
Saliva
1
2005
186
0.020
Why?
Middle Aged
2
2020
27296
0.020
Why?
Tomography, X-Ray Computed
1
2014
2401
0.020
Why?
Blood Glucose
1
2013
1924
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
75
0.010
Why?
Body Mass Index
1
2011
2064
0.010
Why?
Aging
2
2003
1663
0.010
Why?
Tissue Distribution
1
1984
328
0.010
Why?
Epithelium
1
1984
302
0.010
Why?
Anti-Bacterial Agents
1
1993
1499
0.010
Why?
Infusions, Intravenous
1
2003
375
0.010
Why?
Reference Values
1
2003
757
0.010
Why?
Mice, Inbred BALB C
1
1984
1185
0.010
Why?
Suspensions
1
2000
30
0.010
Why?
Urban Population
1
2003
408
0.010
Why?
Capsules
1
2000
34
0.010
Why?
Drug Tolerance
1
2000
78
0.010
Why?
Cytomegalovirus
1
2000
146
0.010
Why?
Signal Transduction
1
2012
4607
0.010
Why?
Epithelial Cells
1
1984
940
0.010
Why?
Administration, Oral
1
2000
744
0.010
Why?
Macrophages
1
1984
1297
0.010
Why?
Immunization
1
2000
410
0.010
Why?
Time Factors
1
2008
6265
0.010
Why?
Recombinant Proteins
1
2000
1264
0.010
Why?
Mice
1
1984
15309
0.000
Why?
Tail
1
1987
29
0.000
Why?
Phosphocreatine
1
1987
37
0.000
Why?
Salamandridae
1
1987
26
0.000
Why?
Animals
2
1987
32774
0.000
Why?
Aged
1
1984
19478
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
494
0.000
Why?
Adenosine Triphosphate
1
1987
438
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)